Results 61 to 70 of about 179,854 (236)

An Investigation into the Quality of Medicines in Yangon, Myanmar

Pharmacy, 2018
Many poor-quality medicines are supplied to patients mainly in developing countries. No systematic survey on counterfeit medicines has been conducted in Myanmar since 1999. The purpose of this study was to investigate the current situation of substandard
Md. Rafiqul Islam, Naoko Yoshida, Kazuko Kimura, Chisana Uwatoko, Mohammad Sofiqur Rahman, Shoma Kumada, Jamie Endo, Kana Ito, Tsuyoshi Tanimoto, Theingi Zin, Hirohito Tsuboi   +10 more
doaj   +1 more source

Advancing health system strengthening through improving access to medicines: A review of local manufacturing policies in Ghana

Medicine Access @ Point of Care, 2020
Providing access to quality-assured medicines is a fundamental component of strengthening health systems. Yet, the World Health Organization (WHO) estimates that 13.6% of all medicines in low- and middle-income countries (LMIC’s) may be substandard or ...
Kwame Peprah Boaitey, Chloe Tuck
doaj   +1 more source

Substandard and falsified medicines in the UK: a retrospective review of drug alerts (2001-2011) [PDF]

, 2013
Objective: To determine the extent of substandard and falsified medicines in the UK. Design: A retrospective review of drug alerts and company-led recalls.
Choonara, Imti, Sammons, Helen, Almuzaini, Tariq   +2 more
core   +1 more source

Immigration detention centers as torturing environments: Ethical reckonings, radical refusals, and implications for a psychology of resistance

American Journal of Community Psychology, EarlyView.
Abstract This paper examines psychologists' ethical dilemmas in immigration detention centers. Using critical psychology, border, and detention scholarship, it highlights psychologists' historical complicity in state violence, from the U.S. Enhanced Interrogation Program to current border regimes.
Francesca Esposito, Federica de Cordova, Julia Manek, Sara Buckingham, Camilla Ponti, Francesco Tommasi, Bradley Olson   +6 more
wiley   +1 more source

Can NGOs Regulate Medicines Markets? Social Enterprise in Wholesaling, and Access to Essential Medicines. [PDF]

, 2011
Citizens of high income countries rely on highly regulated medicines markets. However low income countries' impoverished populations generally struggle for access to essential medicines through out-of-pocket purchase on poorly regulated markets; results ...
Mujinja, P.G.M, Chaudhuri, Sudip, Mujinja Phares GM, Mackintosh Maureen, Maureen Mackintosh, Mackintosh, M., Phares GM Mujinja, Sudip Chaudhuri, Mujinja, Phares Gm, Mujinja, Phares G.M., Mackintosh, Maureen, Chaudhuri Sudip, Chaudhuri, S.   +12 more
core   +1 more source

Integrating One Health to Mitigate the Emergence and Spread of Antimicrobial Resistance in Livestock and Aquaculture

Animal Research and One Health, EarlyView.
Antimicrobial resistance (AMR) is an escalating global threat driven by antimicrobial use in aquaculture and livestock. Resistant pathogens and genes can spread across humans, animals, and the environment through interconnected ecosystems. Using a One Health approach, this review emphasizes antimicrobial stewardship, regulatory strengthening, enhanced ...
Mir Mohammad Ali, Delower Hossain, Ridwan Olamilekan Adesola, Anum Hanif, Shamsaldeen Ibrahim Saeed, Muhammad Abdul Mannan, Anoar Jamai Masroure, Kazi Estieque Alam, Md Kamal Hossain, Sabiha Zarin Tasnim Bristi, Md Jisan Ahmed   +10 more
wiley   +1 more source

Capacity building in medicines development and regulation in Africa—Overview on recent progress

British Journal of Clinical Pharmacology, EarlyView.
Aims Despite advances in health research and digital innovation, many African countries continue to face substantial resource constraints, fragmented capacity‐building efforts and a shortage of skilled professionals in medicines development and regulatory science.
Tirhani Maluleke, Emile Malan, Michael Reid, Patrick Bouic, Haylene Nell, Goonaseelan Pillai, Catriona Waitt, Bernd Rosenkranz   +7 more
wiley   +1 more source

The need for comprehensive and multidisciplinary training in substandard and falsified medicines for pharmacists [PDF]

BMJ Global Health, 2019
The global burden of substandard and falsified (SF) medicines is only beginning to be better understood. A 2017 literature review by WHO estimated a 10.5% observed failure rate of the analysed medical product samples in low-income and middle-income countries.1 The report also estimated that between 72 430 and 169 271 deaths in children under 5 with ...
Alessandra Ferrario, Ebiowei Samuel F Orubu, Moji Christianah Adeyeye, Muhammad H Zaman, Veronika J Wirtz   +4 more
openaire   +3 more sources

Framing National Education in Hong Kong: A frame analysis of power dynamics in stakeholders' competing narratives

British Educational Research Journal, EarlyView.
Abstract This article examines how national education in Hong Kong functions as a contested arena in which state and non‐state actors struggle over the meaning of citizenship, identity and schooling. Using inductive frame analysis of 319 news articles (2020–2025) from five Chinese‐ and English‐language outlets, it identifies diagnostic, prognostic and ...
Jason Cong Lin
wiley   +1 more source

Medicine quality assessment in Nepal using semi randomised sampling and evaluation of a small scale dissolution test and portable Raman spectrometers

Scientific Reports
Substandard and falsified medicines threaten global health and require reliable data and screening technologies to combat their spread. This study examined the quality of 241 samples containing azithromycin, cefixime, esomeprazole and losartan collected ...
Robin Schreiber, Md. Ahsanul Haque, Mohammad Sofiqur Rahman, Bhupendra Kumar Poudel, Balmukunda Regmi, Kazuko Kimura, Naoko Yoshida   +6 more
doaj   +1 more source